Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Lam

Showing results (221-230 of 436) with videos related to

Pageof 44
Sort By:
Current Oncology (Toronto, Ont.)|June 27, 2023
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack YearsAli Silver, Cheryl Ho, Qian Ye, et al.
Journal of Bronchology & Interventional Pulmonology|April 18, 2018
Initial Clinical Experience With a Flexible Peripheral 21-G Needle DeviceAlain Tremblay, Renelle Myers, Eve-Lea Beaudoin, et al.
European Radiology|March 16, 2017
Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelinesSarah J van Riel, Francesco Ciompi, Colin Jacobs, et al.
Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.
The Journal of Clinical Investigation|September 14, 2011
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancerDaniel T Starczynowski, William W Lockwood, Sophie Deléhouzée, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Epigenetic down-regulation of death-associated protein kinase in lung cancersShinichi Toyooka, Kiyomi O Toyooka, Kuniharu Miyajima, et al.
British Journal of Cancer|June 18, 2024
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage responseAmy L Nagelberg, Tianna S Sihota, Yu-Chi Chuang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancerStephen Lam, Peter Boyle, Graham F Healey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 5, 2013
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistanceXin Dong, Dong Lin, Chris Low, et al.
BMC Cancer|October 25, 2014
Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyEmily A Vucic, Kelsie L Thu, Larissa A Pikor, et al.
Pageof 44

Showing results (221-230 of 436) with videos related to

Sort By:
Pageof 44
Current Oncology (Toronto, Ont.)|June 27, 2023
Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack YearsAli Silver, Cheryl Ho, Qian Ye, et al.
Journal of Bronchology & Interventional Pulmonology|April 18, 2018
Initial Clinical Experience With a Flexible Peripheral 21-G Needle DeviceAlain Tremblay, Renelle Myers, Eve-Lea Beaudoin, et al.
European Radiology|March 16, 2017
Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelinesSarah J van Riel, Francesco Ciompi, Colin Jacobs, et al.
Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.
The Journal of Clinical Investigation|September 14, 2011
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancerDaniel T Starczynowski, William W Lockwood, Sophie Deléhouzée, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Epigenetic down-regulation of death-associated protein kinase in lung cancersShinichi Toyooka, Kiyomi O Toyooka, Kuniharu Miyajima, et al.
British Journal of Cancer|June 18, 2024
Integrative genomics identifies SHPRH as a tumor suppressor gene in lung adenocarcinoma that regulates DNA damage responseAmy L Nagelberg, Tianna S Sihota, Yu-Chi Chuang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancerStephen Lam, Peter Boyle, Graham F Healey, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 5, 2013
Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistanceXin Dong, Dong Lin, Chris Low, et al.
BMC Cancer|October 25, 2014
Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biologyEmily A Vucic, Kelsie L Thu, Larissa A Pikor, et al.
Pageof 44